0DRP logo

Biohit Oyj LSE:0DRP Stock Report

Last Price

€2.69

Market Cap

€40.8m

7D

1.5%

1Y

n/a

Updated

18 May, 2025

Data

Company Financials +

Biohit Oyj

LSE:0DRP Stock Report

Market Cap: €40.8m

0DRP Stock Overview

A biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. More details

0DRP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 45.4% below our estimate of its fair value

Earnings are forecast to grow 10.46% per year

Earnings grew by 38.7% over the past year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (€41M)


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Biohit Oyj Competitors

Price History & Performance

Summary of share price highs, lows and changes for Biohit Oyj
Historical stock prices
Current Share Price€2.69
52 Week High€3.53
52 Week Low€2.16
Beta0.59
1 Month Change5.70%
3 Month Change-8.50%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-46.25%

Recent News & Updates

Recent updates

Shareholder Returns

0DRPGB Medical EquipmentGB Market
7D1.5%1.7%0.9%
1Yn/a3.2%0.7%

Return vs Industry: Insufficient data to determine how 0DRP performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0DRP performed against the UK Market.

Price Volatility

Is 0DRP's price volatile compared to industry and market?
0DRP volatility
0DRP Average Weekly Movement4.3%
Medical Equipment Industry Average Movement6.1%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market3.2%

Stable Share Price: 0DRP has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine 0DRP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
198846Jussi Hahtelawww.biohithealthcare.com

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; BIOHIT Active B12, a test for measuring the concentration of total vitamin-B12 in the serum; BIOHIT Total 25OH Vitamin D, a test for determination of 25-hydroxyvitamin D2 and D3; and BIOHIT Calprotectin test, a quantitative test that provides a reliable differentiation between inflammatory bowel diseases and irritable bowel syndrome. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H.

Biohit Oyj Fundamentals Summary

How do Biohit Oyj's earnings and revenue compare to its market cap?
0DRP fundamental statistics
Market cap€40.85m
Earnings (TTM)€2.57m
Revenue (TTM)€14.28m

15.9x

P/E Ratio

2.9x

P/S Ratio

Is 0DRP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0DRP income statement (TTM)
Revenue€14.28m
Cost of Revenue€4.94m
Gross Profit€9.34m
Other Expenses€6.77m
Earnings€2.57m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 06, 2025

Earnings per share (EPS)0.17
Gross Margin65.39%
Net Profit Margin17.98%
Debt/Equity Ratio0%

How did 0DRP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/18 05:46
End of Day Share Price 2025/05/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biohit Oyj is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Antti SiltanenInderes Oy